Hemogenyx Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Hemogenyx Pharmaceuticals has a total shareholder equity of £2.8M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £6.1M and £3.3M respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£1.25m |
| Equity | UK£2.78m |
| Total liabilities | UK£3.32m |
| Total assets | UK£6.11m |
Recent financial health updates
Is Hemogenyx Pharmaceuticals (LON:HEMO) In A Good Position To Deliver On Growth Plans?
Aug 21
Will Hemogenyx Pharmaceuticals (LON:HEMO) Spend Its Cash Wisely?
May 04We Think Hemogenyx Pharmaceuticals (LON:HEMO) Needs To Drive Business Growth Carefully
Jan 06Hemogenyx Pharmaceuticals (LON:HEMO) Has Debt But No Earnings; Should You Worry?
Oct 09Recent updates
Is Hemogenyx Pharmaceuticals (LON:HEMO) In A Good Position To Deliver On Growth Plans?
Aug 21Will Hemogenyx Pharmaceuticals (LON:HEMO) Spend Its Cash Wisely?
May 04We Think Hemogenyx Pharmaceuticals (LON:HEMO) Needs To Drive Business Growth Carefully
Jan 06Hemogenyx Pharmaceuticals (LON:HEMO) Has Debt But No Earnings; Should You Worry?
Oct 09Financial Position Analysis
Short Term Liabilities: HEMO's short term assets (£2.2M) exceed its short term liabilities (£652.1K).
Long Term Liabilities: HEMO's short term assets (£2.2M) do not cover its long term liabilities (£2.7M).
Debt to Equity History and Analysis
Debt Level: HEMO is debt free.
Reducing Debt: HEMO has no debt compared to 5 years ago when its debt to equity ratio was 122.3%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HEMO has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: HEMO is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.